The classic Hollywood depiction of a scientist is a person working in solitude. Nothing could be further from the truth, especially in today’s high-paced, highly connected, technology-driven world. Many novel discoveries are the result of the combined work of teams of scientists from diverse fields. Graduate school is a critical time to master the skill Read more
Research
Like most 23-year-olds, Erica Sellers didn’t give much thought to an unexpected, life-changing event. On April 9, 2013, a routine bike ride from her Bronx studio production job to her former Upper West Side apartment changed all that. She was struck by an SUV at a Bronx intersection and thrown to the ground. She remembers landing with Read more
Editors’ Note: An Einstein-led study with an average follow-up of nearly four years found that 26 percent of initially healthy people over age 60 met criteria for a predementia condition known as Motoric Cognitive Risk Syndrome (MCR). The research was published last week in Neurology, the medical journal of the American Academy of Neurology. MCR Read more
Every day we learn of new suspected cases of Ebola infection in the United States, causing worries among the population and renewed efforts by the Centers for Disease Control and Prevention to contain the epidemic. A student in the postgraduate course in research ethics that I teach at Albert Einstein College of Medicine recently asked Read more
EDITORS’ NOTE: Choosing a research lab is a pivotal decision in the trajectory of a biomedical sciences graduate student or physician scientist. After two or three laboratory rotations, Ph.D. candidates (at the end of the first year) and M.D./Ph.D. candidates (at the end of the second year) determine which labs are exploring the scientific questions Read more
One thousand dollars per pill? A single treatment course for hepatitis C virus to cost $83,000? How can those prices be justified? The drug-discovery process is a long one, fraught with disappointments and massive investment, no matter what the outcome. Some pharmaceutical companies argue that the high prices charged for their rare “blockbuster” drugs help Read more
